Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Thyroid hormone disorder drugs
    • 1.2.1.2 Diabetes drugs
    • 1.2.1.3 Human growth hormone
    • 1.2.1.4 Testosterone replacement therapy
  • 1.2.2 by Application
    • 1.2.2.1 Drugstore
    • 1.2.2.2 Hospital
    • 1.2.2.3 Others
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Thyroid hormone disorder drugs Market, 2013-2018
  • 4.1.2 Diabetes drugs Market, 2013-2018
  • 4.1.3 Human growth hormone Market, 2013-2018
  • 4.1.4 Testosterone replacement therapy Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Thyroid hormone disorder drugs Market Forecast, 2019-2024
  • 4.2.2 Diabetes drugs Market Forecast, 2019-2024
  • 4.2.3 Human growth hormone Market Forecast, 2019-2024
  • 4.2.4 Testosterone replacement therapy Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Drugstore Market, 2013-2018
  • 5.1.2 Hospital Market, 2013-2018
  • 5.1.3 Others Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Drugstore Market Forecast, 2019-2024
  • 5.2.2 Hospital Market Forecast, 2019-2024
  • 5.2.3 Others Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 Novo Nordisk
• 8.2 Sanofi
• 8.3 Merck
• 8.4 Eli Lily
• 8.5 AstraZeneca
• 8.6 AbbVie
• 8.7 GSK
• 8.8 Bayer
• 8.9 Astellas Pharma

9 Conclusion

Summary
The global Endocrinology Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Thyroid hormone disorder drugs
Diabetes drugs
Human growth hormone
Testosterone replacement therapy
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
AbbVie
GSK
Bayer
Astellas Pharma
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Drugstore
Hospital
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa